share_log

AbbVie | 144: Notice of proposed sale of securities pursuant to Rule 144

艾伯維公司 | 144:擬議出售證券

美股SEC公告 ·  02/24 05:10

牛牛AI助理已提取核心訊息

AbbVie Inc. officer Perry C Siatias is set to sell 13,753 shares of the company's common stock on February 23, 2024, according to a recent filing. The shares, valued at approximately $2.44 million, were acquired on the same date through the exercise of stock options. The transaction involved a cash payment made by Siatias to the issuer. This planned sale follows a previous transaction in the past three months where Siatias sold 2,919 shares, generating gross proceeds of $496,230.
AbbVie Inc. officer Perry C Siatias is set to sell 13,753 shares of the company's common stock on February 23, 2024, according to a recent filing. The shares, valued at approximately $2.44 million, were acquired on the same date through the exercise of stock options. The transaction involved a cash payment made by Siatias to the issuer. This planned sale follows a previous transaction in the past three months where Siatias sold 2,919 shares, generating gross proceeds of $496,230.
根據最近的一份文件,艾伯維公司高管佩裏·西亞蒂亞斯定於2024年2月23日出售該公司13,753股普通股。這些股票價值約244萬美元,於同日通過行使股票期權收購。該交易涉及Siatias向發行人支付的現金。此次計劃出售是在過去三個月中進行的一筆交易之後進行的,當時西亞蒂亞斯出售了2,919股股票,總收益爲496,230美元。
根據最近的一份文件,艾伯維公司高管佩裏·西亞蒂亞斯定於2024年2月23日出售該公司13,753股普通股。這些股票價值約244萬美元,於同日通過行使股票期權收購。該交易涉及Siatias向發行人支付的現金。此次計劃出售是在過去三個月中進行的一筆交易之後進行的,當時西亞蒂亞斯出售了2,919股股票,總收益爲496,230美元。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。